Daniela Cavaco

ORCID: 0000-0001-9486-9791
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Thyroid Cancer Diagnosis and Treatment
  • Adrenal and Paraganglionic Tumors
  • Pituitary Gland Disorders and Treatments
  • Neuroendocrine Tumor Research Advances
  • Childhood Cancer Survivors' Quality of Life
  • Neurofibromatosis and Schwannoma Cases
  • Microbial Inactivation Methods
  • Bone health and treatments
  • Head and Neck Anomalies
  • Cancer, Hypoxia, and Metabolism
  • Meningioma and schwannoma management
  • Acute Lymphoblastic Leukemia research
  • Parathyroid Disorders and Treatments
  • Growth Hormone and Insulin-like Growth Factors
  • Thyroid and Parathyroid Surgery
  • Cancer Diagnosis and Treatment
  • Cancer Risks and Factors
  • Genetic factors in colorectal cancer
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Magnesium in Health and Disease
  • Neuroblastoma Research and Treatments
  • Sarcoidosis and Beryllium Toxicity Research
  • Glioma Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Medical Imaging and Pathology Studies

Instituto Português de Oncologia Francisco Gentil
2020-2022

Hospital de Santa Maria
2021

Diffuse sclerosing variant of PTC (DSV-PTC) is an uncommon subtype thyroid cancer. Although aggressive behavior often recognized, prognostic significance still under debate.To describe the clinicopathological features and outcomes a series DSV-PTC patients.Retrospective data collection involving 33 patients diagnosed with followed at Endocrine Department Portuguese Institute Oncology in Lisbon between 1981 2020.Twenty-six (78.8%) were females mean age presentation 29.4 ± 11.7 years old. Mean...

10.1530/etj-21-0020 article EN cc-by-nc-nd European Thyroid Journal 2022-01-04

Haematopoietic stem cell transplantation (HSCT) is a therapeutic option for numerous haematologic diseases and solid tumours. Increasing indications HSCT reduction in associated mortality have been raising the number of paediatric survivors their long-term toxicities.To characterize endocrine disorders developed after HSCT.Retrospective analysis 152 patients submitted to age with at least 24 months follow-up our late-effects clinics.Patients were followed up 9.9 (interquartile range [IQR]:...

10.1111/cen.14826 article EN Clinical Endocrinology 2022-09-26

Cancer survivors are at an increased risk of adverse outcomes, including thyroid neoplasms, given the high radiosensitivity this gland. The aim study is to assess incidence and timeframe complications in cancer patients, followed systematically since their radiation therapy, identify factors for development hypothyroidism cancer.We performed a retrospective study, 282 subjects, who received neck, craniospinal, or total body irradiation (TBI). Patients were grouped into four primary...

10.1111/cen.14665 article EN Clinical Endocrinology 2022-01-03

Diffuse thyroid lipomatosis is a rare histopathological condition of unknown etiology, characterized by diffuse fatty infiltration the stroma, which can result in goiter with compressive symptoms. We report case 46-year-old man 1-year history progressive enlargement Imaging studies revealed multiple coalescent nodules. The patient underwent surgery, and microscopic appearance stroma mature adipose tissue associated amyloid deposition. A final diagnosis gland was established. This represents...

10.1159/000518444 article EN European Thyroid Journal 2021-01-01

Abstract Background Neurofibromatosis type 1 (NF1) is a common genetic disorder of phenotypic variability with age-dependent penetrance. This study describes the diagnosis, clinical characterization, management, and outcomes large patient cohort plexiform neurofibroma (PN) treated selumetinib in real-world setting. Methods single-center observational consecutively enrolled patients NF1-PN from April 2018 to 2023. Data on features, tumor types locations, results tests were recorded at...

10.1093/noajnl/vdae177 article EN cc-by-nc Neuro-Oncology Advances 2024-01-01

ABSTRACT X-linked hypophosphataemic rickets (XLH) is a rare disease caused by mutation in the phosphate-regulating neutral endopeptidase (PHEX) gene, located on X chromosome. This gene encodes endopeptidase, and its inactivation leads to increased levels of circulating phosphatonins responsible for renal phosphate loss. The treatment XLH still carried out with long-term administration calcitriol, which can be complicated hyperparathyroidism, nephrocalcinosis, failure, hypertension. We...

10.1093/mrcr/rxab031 article EN Modern Rheumatology Case Reports 2021-09-25

Lung is the most common site of distant metastases from differentiated thyroid carcinoma (DTC).To investigate outcomes a cohort patients with DTC and lung (LM).A retrospective analysis 271 LM was performed.The female-to-male ratio 1:1 median follow-up time 5.9 (1.1-38.4) years. Papillary (PTC) frequent type (83.4%), mainly classic variant, followed by follicular (FTC, 10.3%) Hürthle cell (HTC, 6.3%). The prevalence PTC, FTC HCC different between micronodular macronodular groups [87.4%, 6.3%...

10.1111/cen.14700 article EN Clinical Endocrinology 2022-02-22

Abstract The “flip‐flop” phenomenon may be present in differentiated progressive thyroid cancer. A high suspicion index must maintained when this coexists with a tumor burden, due to the risk of appearance distinct tumors.

10.1002/ccr3.4770 article EN cc-by-nc-nd Clinical Case Reports 2021-08-30

There is a great controversy about hormonal replacement therapy in women among the members of scientific community. Cancer survivors have sometimes had their ovary function totally or partially destroyed, thus affecting development and quality life. In this study, we were looking for adverse effects caused, eventually, by estroprogestative cohort supplemented survivors. The occurrence breast cancer was our main concern. Ours retrospective study based on clinical records 174 several diseases....

10.1159/000506395 article EN cc-by-nc Case Reports in Oncology 2020-03-31

Advanced papillary thyroid carcinoma (PTC) with cutaneous metastases may cause pain, ulceration, and bleeding. Electrochemotherapy (ECT) is a minimally invasive treatment of tumors located in the skin subcutaneous tissue. The electric pulses potentiate toxicity cytostatic agents entering tumor cell. It highly effective especially to relieve pain improve quality life. adverse events are local transient. A case progressive metastatic PTC who developed bleeding treated ECT described.

10.1159/000507888 article EN European Thyroid Journal 2020-01-01

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)

10.1530/endoabs.65.p158 article EN Endocrine Abstracts 2019-11-06

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)

10.1530/endoabs.67.gp15 article EN Endocrine Abstracts 2019-11-19

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)

10.1530/endoabs.70.ep436 article EN Endocrine Abstracts 2020-08-21

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)

10.1530/endoabs.70.ep64 article EN Endocrine Abstracts 2020-08-21

Abstract Purpose: The use of FDG-PET/TC for cancer staging has been leading to the increasing diagnosis adrenal lesions, which usually represent a clinical challenge. Our aim was characterize lesions found in FDG-PET patients followed center. Methods: Retrospective analysis all studies performed our center last 10 years. Exams reporting CT component and/or anomalous FDG uptake were selected. Cases characterized regarding clinical, laboratorial, imaging and pathological findings. Results: We...

10.21203/rs.3.rs-975182/v1 preprint EN cc-by Research Square (Research Square) 2021-10-19

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)

10.1530/endoabs.75.p01 article EN Endocrine Abstracts 2021-08-31
Coming Soon ...